Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic... von Mavroudis, D., Saloustros, E., Malamos, N., Kakolyris, S., Boukovinas, I., Papakotoulas, P., Kentepozidis, N., Ziras, N., Georgoulias, V.

Volltext

Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) partici... von Souglakos, J., Boukovinas, I., Kakolyris, S., Xynogalos, S., Ziras, N., Athanasiadis, A., Androulakis, N., Christopoulou, A., Vaslamatzis, M., Ardavanis, A., Emmanouilides, C., Bompolaki, I., Kourousis, C., Makrantonakis, P., Christofyllakis, C., Athanasiadis, E., Kentepozidis, N., Karampeazis, A., Katopodi, U., Anagnosopoulos, A., Papadopoulos, G., Prinarakis, E., Kalisperi, A., Mavroudis, D., Georgoulias, V.

Volltext

Evaluation of artificial time series microarray data for dynamic gene regulatory network inference von Xenitidis, P., Seimenis, I., Kakolyris, S., Adamopoulos, A.

Volltext

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cance... von Souglakos, J, Androulakis, N, Syrigos, K, Polyzos, A, Ziras, N, Athanasiadis, A, Kakolyris, S, Tsousis, S, Kouroussis, Ch, Vamvakas, L, Kalykaki, A, Samonis, G, Mavroudis, D, Georgoulias, V

Volltext

Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer von Balgkouranidou, I, Chimonidou, M, Milaki, G, Tsarouxa, E G, Kakolyris, S, Welch, D R, Georgoulias, V, Lianidou, E S

Volltext

Corrigendum to Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study b... von Mavroudis, D., Saloustros, E., Malamos, N., Kakolyris, S., Boukovinas, I., Papakotoulas, P., Kentepozidis, N., Ziras, N., Georgoulias, V.

Volltext

Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer:... von Mavroudis, D., Matikas, A., Malamos, N., Papakotoulas, P., Kakolyris, S., Boukovinas, I., Athanasiadis, A., Kentepozidis, N., Ziras, N., Katsaounis, P., Saloustros, E., Georgoulias, V.

Volltext

Molecular Detection of Cytokeratin-19–Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Significance von STATHOPOULOU, A, VLACHONIKOLIS, I, REPPA, D, GEORGOULIAS, V, MAVROUDIS, D, PERRAKI, M, KOUROUSSIS, Ch, APOSTOLAKI, S, MALAMOS, N, KAKOLYRIS, S, KOTSAKIS, A, XENIDIS, N

Volltext

Prognostic significance of SOX17 and WNT5a promoter methylation status in circulating cell-free DNA metastatic colorectal cancer patients von Vagionas, A, Balgkouranidou, I, Koukaki, T, Biziota, E, Amarantidis, K, Kakolyris, S, Xenidis, N

Volltext

Molecular Pathogenesis of Pancreatic Cancer and Clinical Perspectives von Matthaios, D., Zarogoulidis, P., Balgouranidou, I., Chatzaki, E., Kakolyris, S.

Volltext

Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of pa... von Souglakos, J, Ziras, N, Kakolyris, S, Boukovinas, I, Kentepozidis, N, Makrantonakis, P, Xynogalos, S, Christophyllakis, Ch, Kouroussis, Ch, Vamvakas, L, Georgoulias, V, Polyzos, A

Volltext

Concentration of circulating tumour DNA in patients with metastatic gastric cancer and its prognostic significance von Karamitrousis, E., Balgkouranidou, I., Xenidis, N., Amarantidis, K., Biziota, E., Koukaki, T., Kakolyris, S.

Volltext

2388 Serum mass spectrometry analysis in hepatocellular carcinoma (HCC) patients treated with sorafenib (S) von Chelis, L, Kakolyris, S, Mimidis, K, Xenidis, N, Amarantidiss, K, Meyer, K, Roder, H

Volltext

Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer von Xenidis, N, Perraki, M, Apostolaki, S, Agelaki, S, Kalbakis, K, Vardakis, N, Kalykaki, A, Xyrafas, A, Kakolyris, S, Mavroudis, D, Georgoulias, V

Volltext

TGF-β induced epithelial-mesenchymal transition modeling von Xenitidis, P, Seimenis, I, Kakolyris, S, Adamopoulos, A

Volltext

H2AX and lung cancer: Is it the Ariadne's thread? von Matthaios, D., Bouros, D., Kakolyris, S.

Volltext

Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer von Xenidis, N., Markos, V., Apostolaki, S., Perraki, M., Pallis, A., Sfakiotaki, G., Papadatos-Pastos, D., Kalmanti, L., Kafousi, M., Stathopoulos, E., Kakolyris, S., Mavroudis, D., Georgoulias, V.

Volltext

γ-H2AX : A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer von Rigas, A., Kakolyris, Stylianos, Romanidis, K., Papaschinopoulos, Garyfalos, Karakitsos, P., Bouros, Demosthenes, Chatzimichail, E., Matthaios, D.

Volltext

Triplet Combination With Irinotecan Plus Oxaliplatin Plus Continuous-Infusion Fluorouracil and Leucovorin as First-Line Treatment in Metastatic Colorectal Cancer: A Multicenter Pha... von SOUGLAKOS, J, MAVROUDIS, D, SAMONIS, G, GEORGOULIAS, V, KAKOLYRIS, S, KOUROUSIS, Ch, VARDAKIS, N, ANDROULAKIS, N, AGELAKI, S, KALBAKIS, K, TSETIS, D, ATHANASIADIS, N

Volltext

Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer von Mavroudis, D., Papakotoulas, P., Ardavanis, A., Syrigos, K., Kakolyris, S., Ziras, N., Kouroussis, C., Malamos, N., Polyzos, A., Christophyllakis, C., Kentepozidis, N., Georgoulias, V.

Volltext